EPRX · NASDAQ
Eupraxia Pharmaceuticals (EPRX) Stock Price & Fundamentals
Eupraxia Pharmaceuticals (EPRX) closed at $550.08 on Oct 9, 2026, up 0.03% from the previous close of $549.94.
Share price, past year
1Y +11.84%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $550.08 |
| Sep 30, 2026 | $555.07 |
| Aug 31, 2026 | $531.56 |
| Jul 31, 2026 | $529.03 |
| Jun 30, 2026 | $562.02 |
| May 29, 2026 | $620.51 |
| Apr 30, 2026 | $584.25 |
| Mar 31, 2026 | $556.87 |
| Feb 27, 2026 | $576.31 |
| Jan 30, 2026 | $565.41 |
| Dec 31, 2025 | $535.66 |
| Nov 28, 2025 | $502.86 |
| Oct 31, 2025 | $507.17 |
Key statistics
- Market cap
- $28.57B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 51.9M
- Dividend yield
- —
- 52-week range
- $483.84 – $630.57
Eupraxia Pharmaceuticals's market cap is $28.57B, based on a share price of $550.08 and 51.9M shares outstanding as of Dec 31, 2025.
Financials
Eupraxia Pharmaceuticals reported revenue of $0.00 for fiscal 2025.
Eupraxia Pharmaceuticals reported a net loss of $38.58M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $0.00 | — | −$38.58M | — | −$1.03 | — |
| FY2024ended Dec 31, 2024 | $0.00 | — | −$25.50M | — | −$0.76 | — |
| FY2023ended Dec 31, 2023 | $0.00 | — | −$28.22M | — | −$1.17 | — |
Company profile
- Name
- Eupraxia Pharmaceuticals Inc.
- Ticker
- EPRX
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 2198 Yukon Street, Vancouver, V5Y 3P1
- Incorporated in
- A1
- Fiscal year ends
- December
- SEC CIK
- 0001581178
Frequently asked questions
What is Eupraxia Pharmaceuticals's stock price?
Eupraxia Pharmaceuticals (EPRX) closed at $550.08 on Oct 9, 2026, up 0.03% from the previous close of $549.94.
What is Eupraxia Pharmaceuticals's market cap?
Eupraxia Pharmaceuticals's market cap is $28.57B, based on a share price of $550.08 and 51.9M shares outstanding as of Dec 31, 2025.
How much revenue does Eupraxia Pharmaceuticals make?
Eupraxia Pharmaceuticals reported revenue of $0.00 for fiscal 2025.
Sources and methodology
Fundamentals come from Eupraxia Pharmaceuticals Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures